| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S80495-5mg买3赠1 |
99.50% | ￥350.00 |
7 | - | - | - | - |
|
S80495-10mg促销 |
99.50% | ￥550.00 ￥450.00 |
2 | 2 | 2 | - | - |
|
S80495-50mg促销 |
99.50% | ￥800.00 ￥540.00 |
8 | - | - | - | - |
|
S80495-100mg买3赠1 |
≥99% | ￥950.00 |
货期：2-3天 | - | - | - | - |
|
S80495-1g |
≥99% | ￥3080.00 |
货期：2-3天 | - | - | - | - |
|
| 产品描述： | Pretomanid (PA-824) is an antibiotic used for the research of multi-drug-resistant tuberculosis affecting the lungs. Pretomanid exhibits a sub-micromolar MIC against M. tuberculosis (MTB). The MIC values of PA-824 against a panel of MTB pan-sensitive and Rifampin mono-resistant clinical isolates range from 0.015 to 0.25 µg/mL | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | Tuberculosis.;Antibacterial;Antibiotic | ||||||||||||||||||||
| 参考文献： | 1. Stover CK, et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature. 2000 Jun 22;405(6789):962-6. 2. Lenaerts AJ, et al. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models. Antimicrob Agents Chemother. 2005 Jun;49(6):2294-301. 3. Manjunatha UH, et al. Mycobacterium leprae is naturally resistant to PA-824. Antimicrob Agents Chemother. 2006 Oct;50(10):3350-4. | ||||||||||||||||||||
| 溶解性： | DMSO : 125 mg/mL (347.94 mM; Need ultrasonic) | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京